Your cart is empty.
Männedorf, Switzerland, August 08, 2012 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2012 on Thursday, August 16th, 2012 at 10:00 CET. The results will be published on August 16th, 2012 at 7:00 CET.The conference call will be audio-webcast with synchronized presentation slides. Interested parties may access the webcast via Tecan’s homepage www.tecan.com. A link to the webcast will be provided immediately prior to the event.
Interested parties can also listen to the conference call by phone.
The dial-in numbers for the call are as follows:
Participants from Europe: +41 91 610 5600 or +44 203 059 58 62 (UK)
Participants from the U.S.: +1 (1) 866 291 4166
Participants should if possible dial in 15 minutes before the start of the event.
On August 16th, the full 2012 Interim Report will be available on the company website www.tecan.com under Investor Relations. An iPad app for Financial Reports of the Tecan Group is also available from the App Store.
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).
For further information
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89